Clinical Trials in Japan / NCT06943417
Starting soon
Not applicable
Safety and Efficacy of Endoscopic Full Thickness Biopsy in Patients With Chronic Intestinal Pseudo-obstruction
NCT06943417 · tracked via the Priya Life Science Japan tracker
Condition(s) studied
Chronic Intestinal Pseudo-obstruction
Investigational drug(s) / intervention(s)
Over the scope clip
Over the scope clip: over the scope clip group
Study summary
To evaluate the safety and efficacy of endoscopic full thickness biopsy for the diagnostic purpose of chronic intestinal pseudo-obstruction.
Eligibility
Inclusion Criteria:
* Patients with chronic pseudo intestinal obstruction or suspected chronic pseudo intestinal obstruction
* Patients who are 18 years of age or older at the time of obtaining consent
* Gender: Any
Exclusion Criteria:
* Patients for whom it is difficult to perform endoscopy
* Patients who cannot obtain consent
* Patients with serious renal, hepatic, or cardiac disease
* Patients who are participating in other clinical research, except for observational research.
* Other patients whom the principal investigator or subinvestigator determines to be inappropriate to conduct this study.
Primary outcome measure(s)
- Percentage of total perforations (intraoperative and delayed perforations) — Immediately after the intervention
Percentage of total perforations (intraoperative and delayed perforations)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| International university health and welfare Narita hospital | Narita | Japan |
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06943417 on ClinicalTrials.gov ↗ ← All trials in Japan